S Ylä-Herttuala Selected Research

S Ylä-Herttuala Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 03/2000
10	Atherosclerosis 06/2008 - 01/2000
8	Glioma (Gliomas) 04/2015 - 01/2000
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2000
3	Herpes Simplex 04/2015 - 01/2000
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2012
2	Neoplasm Metastasis (Metastasis) 11/2019 - 03/2001
2	Hypercholesterolemia 01/2017 - 08/2001
2	Virus Diseases (Viral Diseases) 01/2017 - 01/2015
2	Ischemia 04/2012 - 09/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2012 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 08/2009 - 10/2000
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2009 - 06/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2009 - 01/2000
2	Vesicular Stomatitis 09/2008 - 02/2006
2	Pathologic Constriction (Stenosis) 11/2002 - 01/2000
2	Coronary Disease (Coronary Heart Disease) 09/2001 - 01/2000
2	Vascular Diseases (Vascular Disease) 09/2000 - 01/2000
2	Retinoblastoma (Glioblastoma, Retinal) 09/2000 - 01/2000
1	Obstructive Sleep Apnea 01/2022
1	Thrombosis (Thrombus) 10/2018
1	Focal Infection 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Insulin Resistance 08/2014
1	Weight Gain 08/2014
1	Peripheral Arterial Occlusive Disease 1 04/2012
1	Fibrosis (Cirrhosis) 12/2011
1	Ovarian Neoplasms (Ovarian Cancer) 02/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2009
1	Infections 06/2008
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2008
1	Heterotopic Ossification (Ectopic Ossification) 12/2007
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2006
1	Hyperplasia 11/2005
1	Carcinogenesis 03/2001
1	Breast Neoplasms (Breast Cancer) 03/2001

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2000
9	Thymidine KinaseIBA 04/2015 - 01/2000
5	Ganciclovir (Cytovene)FDA LinkGeneric 04/2015 - 03/2000
4	AntibodiesIBA 07/2009 - 01/2000
3	LipidsIBA 01/2017 - 03/2000
3	EnzymesIBA 04/2015 - 08/2000
3	Therapeutic UsesIBA 12/2013 - 01/2000
3	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 02/2011 - 02/2001
3	Vascular Endothelial Growth Factor DIBA 08/2009 - 02/2001
3	oxidized low density lipoproteinIBA 09/2001 - 01/2000
3	Vascular Endothelial Growth Factor CIBA 03/2001 - 10/2000
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 01/2000
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 09/2001
2	ProdrugsIBA 04/2015 - 12/2013
2	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 06/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2009 - 09/2000
2	LigandsIBA 07/2009 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 02/2006 - 12/2003
2	AutoantibodiesIBA 09/2001 - 01/2000
2	Tissue Inhibitor of MetalloproteinasesIBA 09/2000 - 01/2000
2	Nitric Oxide Synthase (NO Synthase)IBA 09/2000 - 01/2000
2	Scavenger Receptors (Scavenger Receptor)IBA 03/2000 - 01/2000
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Interferon Type IIBA 01/2015
1	InterferonsIBA 01/2015
1	ruxolitinibIBA 01/2015
1	Vascular Endothelial Growth Factor BIBA 08/2014
1	Temozolomide (Temodar)FDA LinkGeneric 12/2013
1	SolutionsIBA 12/2012
1	Liposomes (Liposome)IBA 04/2012
1	AngiopoietinsIBA 02/2011
1	TIE-2 Receptor (Receptor, TIE 2)IBA 02/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2011
1	Urokinase Plasminogen Activator ReceptorsIBA 09/2009
1	Retinaldehyde (Retinal)IBA 08/2009
1	Epidermal Growth Factor (EGF)IBA 07/2009
1	Transferrin Receptors (Transferrin Receptor)IBA 07/2009
1	omega-Chloroacetophenone (Mace)IBA 05/2009
1	Silica GelIBA 01/2009
1	Oxidants (Oxidizing Agents)IBA 09/2008
1	Glycoproteins (Glycoprotein)IBA 09/2008
1	Green Fluorescent ProteinsIBA 09/2008
1	Tobacco Smoke Pollution (Passive Smoking)IBA 06/2008
1	SmokeIBA 06/2008
1	Peptides (Polypeptides)IBA 12/2007
1	EndostatinsIBA 12/2007
1	GTP-Binding Proteins (G-Protein)IBA 02/2006
1	Adenosine DeaminaseIBA 01/2006
1	baysilon (polydimethylsiloxane)IBA 11/2005
1	CholesterolIBA 11/2005
1	Vascular Endothelial Growth FactorsIBA 11/2005
1	Biomarkers (Surrogate Marker)IBA 09/2001
1	Superoxide DismutaseIBA 09/2001
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2001
1	AntioxidantsIBA 06/2001
1	LDL Receptors (LDL Receptor)IBA 06/2001

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2000
2	Stents 10/2018 - 11/2002
2	Drug Therapy (Chemotherapy) 12/2013 - 02/2011
1	Endovascular Procedures 10/2018
1	Transplantation 01/2015
1	Oncolytic Virotherapy 01/2015